cyltezo - adalimumab - adbm
(Adalimumab-Adbm)Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: Cyltezo is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, non-infectious uveitis in adults, and juvenile idiopathic arthritis and uveitis in pediatric patients.